Mitsubishi UFJ Asset Management
RUBY

Mitsubishi UFJ Asset Management’s Rubius Therapeutics, Inc RUBY Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio RUBY Stock Details RUBY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-24,135
Closed -$133K – 1223
2022
Q1 		$133K Buy
24,135
+2,830
+13% +$18K ﹤0.01% 1111
2021
Q4 		$222K Buy
21,305
+9,458
+80% +$131K ﹤0.01% 1066
2021
Q3 		$212K Buy
11,847
+340
+3% +$7.4K ﹤0.01% 1053
2021
Q2 		$281K Buy
+11,507
New +$288K ﹤0.01% 1050

Other funds holding RUBY

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AFM
Abbot Financial Management Andover, Massachusetts $239M AUM 27.19% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Mitsubishi UFJ Asset Management's RUBY Position: Q2 2022 in Review

Mitsubishi UFJ Asset Management sold out of Rubius Therapeutics, Inc (RUBY) in Q2 2022, closing a stake of 24,135 shares — an estimated $133K sold.

Mitsubishi UFJ Asset Management first reported a position in RUBY in Q2 2021 and held it in 4 quarters. The position peaked at $281K in Q2 2021. 72 funds tracked by Wall St. Rank hold RUBY as of Q2 2022.

  • Mitsubishi UFJ Asset Management reported no remaining Rubius Therapeutics, Inc position as of Q2 2022 after selling out during the quarter.
  • Mitsubishi UFJ Asset Management sold 24,135 Rubius Therapeutics, Inc shares in Q2 2022, an estimated $133K.
  • Mitsubishi UFJ Asset Management first reported a position in Rubius Therapeutics, Inc in Q2 2021 and held it in 4 quarters.
  • Mitsubishi UFJ Asset Management's Rubius Therapeutics, Inc position peaked at $281K in Q2 2021.
  • 72 funds tracked by Wall St. Rank held Rubius Therapeutics, Inc as of Q2 2022.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2022, filed 4 Aug 2022.